Covid-19: Johnson & Johnson to Resume Its Vaccine Rollout in Europe

The move came after the E.U.’s drug regulator said the Johnson & Johnson vaccine should carry a warning for a potential risk for rare blood clots, though the agency said it believes the shot’s benefits outweigh risks.

Read the full article here

Related Articles